Evidence-based clinical recommendations for the pharmacological management of rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis, and hydroxychloroquine retinopathy screening for people with systemic lupus erythematosus. Developed by ANZMUSC, Australian Rheumatology Association, and Cochrane Musculoskeletal.